Results 141 to 150 of about 12,554 (221)

Letter to the editor: Is the acellular pertussis vaccine driving the increase in severe whooping cough cases in children? [PDF]

Euro Surveill
Prevost B, Nathan N, Corvol H.
europepmc   +1 more source

OPTIMUM study protocol: an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule. [PDF]

BMJ Open, 2020
Perez Chacon G, Estcourt MJ, Totterdell J, Campbell DE, Perrett KP, Marsh JA, Richmond PC, Wood N, Gold MS, Holt PG, Waddington CS, Snelling TL.   +11 more
europepmc   +1 more source

Vaccine [PDF]

BackgroundHealth-care personnel (HCP) are at risk for exposure to and possible transmission of vaccine-preventable diseases. Receiving recommended vaccines is an essential prevention practice for HCP to protect themselves and their patients. The tetanus,

core  

A Phase 2b Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 6-Valent Group B Streptococcus Vaccine Administered Concomitantly With Tetanus, Diphtheria, and Acellular Pertussis Vaccine in Healthy Nonpregnant Female Individuals. [PDF]

J Infect Dis
Smith WB, Seger W, Chawana R, Skogeby Z, Silmon de Monerri NC, Feng Y, Gaylord M, Jongihlati B, Beeslaar J, Skinner JM, Bickham K, Anderson AS.   +11 more
europepmc   +1 more source

MMWR Morb Mortal Wkly Rep [PDF]

In October 2011, the Advisory Committee on Immunization Practices (ACIP) first recommended the routine administration of a tetanus, diphtheria, and acellular pertussis vaccine (Tdap) during pregnancy as a strategy to protect infants from pertussis (also ...

core  

Immunogenicity and safety of co-administration with the Sabin-strain-based inactivated poliovirus vaccine (vero cell) and the diphtheria-tetanus-acellular pertussis vaccine in eligible children in China: a randomized, controlled, multicenter, non-inferiority trial. [PDF]

Front Immunol
Liu X, Han S, Chen X, Sun L, Wang R, Shi X, Guo Y, Wang H, Chen H, Chang S, Xu X, Zhang C, Wang Y, Zhang D, Hu W, Zhang S.   +15 more
europepmc   +1 more source

Repeated Bordetella pertussis Infections Are Required to Reprogram Acellular Pertussis Vaccine-Primed Host Responses in the Baboon Model. [PDF]

J Infect Dis
Kapil P, Wang Y, Zimmerman L, Gaykema M, Merkel TJ.   +4 more
europepmc   +1 more source

Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial. [PDF]

PLoS Med
Pérez Chacón G, Estcourt MJ, Totterdell J, Marsh JA, Perrett KP, Campbell DE, Wood N, Gold M, Waddington CS, O' Sullivan M, McAlister S, Curtis N, Jones M, McIntyre PB, Holt PG, Richmond PC, Snelling T.   +16 more
europepmc   +1 more source

Maternal Vaccination in Argentina: Tetanus, Diphtheria, and Acellular Pertussis Vaccine Effectiveness During Pregnancy in Preventing Pertussis in Infants <2 Months of Age. [PDF]

Clin Infect Dis, 2020
Romanin V, Acosta AM, Juarez MDV, Briere E, Sanchez SM, Cordoba BL, Sevilla ME, Lucion MF, Urrutia A, Sagradini S, Skoff TH, Vizzotti C.   +11 more
europepmc   +1 more source

Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study. [PDF]

Hum Vaccin Immunother, 2021
Asatryan A, Meyer N, Scherbakov M, Romanenko V, Osipova I, Galustyan A, Shamsheva O, Latysheva T, Myasnikova T, Baudson N, Dodet M, Xavier S, Harrington L, Kuznetsova A, Campora L, Van den Steen P.   +15 more
europepmc   +1 more source